200,000+ products from a single source!

sales@angenechem.com

Home > Allylpalladium

Allylpalladium

The heteroatom possessing bis-allylpalladium analogs were reacted by extending the reaction of bis-allylation. The 2-alkynylisocyanobenzenes, allyl methyl carbonate, and trimethylsilyl azide were reacted by palladium-catalyzed three-component coupling reaction to afford good yields of N-cyanoindoles (Scheme 17).[84] The reaction proceeded through the formation of allylpalladium azide, and subsequently the allylpalladium intermediate was produced by the insertion of divalent carbon of isocyanide into the NPd bond of allylpalladium azide. The allylpalladium intermediate eliminated the nitrogen to form the bis-allylpalladium analog (3-allyl)(3-cyanamido)palladium complex.

 

Yamamoto et al.[85,86] synthesized 2-substituted 3-allylindoles through cyclization of alkynylbenzenes possessing isocyano and isocyanato moieties in the ortho position. The 2-substituted 3-allyl-N-cyanoindoles were formed when o-alkynylisocyanobenzenes, allyl methyl carbonate, and trimethylsilyl azide were reacted through a three-component reaction in Pd2(dba)3.3CHCl3 and tri(2-furyl)phosphine at 100 C. With a number of substituents in the aryl ring good to allowable yields were reported. The Curtius-like rearrangement of p-allylpalladiumintermediate to the palladium-carbodiimide complex was a distinctive and interesting aspect of this mechanism. The palladium-carbodiimide and palladium-cyanamide complexes were in equilibrium. The presence of heteroatom possessing bis-p-allylpalladium complex was also suggested. The insertion of alkyne functionality into the Pd-N bond of intermediate followed by a reductive elimination of Pd(0) formed the N-cyanoindole. At 100 C temperature indoles were obtained whereas, reductive elimination of Pd(0) from the palladium-cyanamide complex occurred to produce allyl cyanamides at lower temperature (up to 40 C).[13,44] Barluenga et al.[87] synthesized indole derivatives by a three-component reaction. This strategy involved a Pd-catalyzed cascade sequence which involved an alkenyl amination, C-arylation and a subsequent intramolecular N-arylation. During the start of the reaction equimolecular amounts of haloalkene, o-dihaloarene, and amines were mixed. The higher reactivity of haloalkene as compared to the haloarene towards the oxidative addition with palladium allowed the unique synthesis of imine intermediate. Further the deprotonation in basic media produced the corresponding aza-allylic anion. The 2-substituted indoles were formed in a subsequent Pd-assisted intermolecular alkylation with the dihalogeno substrate followed by an intramolecular N-arylation. The palladium catalyst was intervened in three different coupling reactions in this cascade reaction. Those three coupling reactions were: intermolecular N-alkenylation, C-arylation, and intramolecular N-arylation (Scheme 18).[88]

 

Barluenga et al.[87] reported a domino reaction of o-halobenzene or o-dihaloarenes sulfonates (o-chlorononaflates were the best substrates) with imines for the preparation of indoles through a selective palladium-catalyzed imine C-arylation followed by an intramolecular C–N bond formation reaction with palladium catalyst (Scheme 19). Palladium catalyst was utilized for the formation of these precursors in concert with cyclization as well as simply mediated the formation of C–N bonds. Barluenga demonstrated the one example where palladium catalyst was used for the formation of two separate bonds; first through arylation of the azaallylic anion of imine the C–C bond was formed and then C-N bond was formed catalytically.[31b,44]

 

The reaction showed wide scope with o-dibromobenzene. The alkyl, aryl, and vinyl substituents were introduced at different positions of pyrrole ring of the indole. The regioselective preparation of indoles substituted in the benzene ring was conducted, with the advantage of different reactivities of Cl, Br, and I in oxidative addition reactions, by reacting o-dihalobenzene derivatives with two different halogens
(Scheme 20).[44,89]

 

A more general approach was developed to influence the regioselectivity using catalyst which affected the alkyne insertion step. Konno[90] found that the bulkier P(o-tol)3 ligand favored the formation of 3-CF3 substituted products whereas PPh3 preferred the generation of 2-CF3 substituted indoles (Scheme 21).


Jorgensen et al.[91] transformed primary allylamines into indoles and aza-indoles by a novel one-flask strategy through sequential aryl amination and Heck cyclization reactions in the presence of a single catalyst (Scheme 22).[92] The precursors for Heck cyclization were generated by an efficient palladium catalyzed C–N bond forming reactions. Jorgensen[91] has shown that how the tandem C–N bond formation (with the aryl-iodide)/Heck cyclization cascade of starting material and allyl amines in the presence of palladium catalyst can afford one pot synthetic protocol for the formation of indoles (Scheme 23).[92,93] After screening, it was found that the dppf ligand in concert with Pd2dba3 was optimum catalyst for these two steps and it afforded a pathway for the synthesis of a variety of 3-substituted indoles.[31b]

 

The 2-haloanilines were coupled with vinylbromides in this method. Barluenga[94] has demonstrated that depending upon the used ligand, this method formed either indoles or simple imines. The indole was synthesized exclusively with bulky phosphines (Scheme 24). The o-bromoanilines were reacted with alkenyl halides for the synthesis of indoles through a domino process through an alkenyl amination followed by an intramolecular Heck reaction. The alkenyl halides reacted in the order as follows: alkenyl bromides > aryl bromides > alkenyl chlorides > aryl chlorides. The combination of 2-dicyclohexylphosphino-N,N-dimethylaminobiphenyl (DavePhos), Pd2(dba)3, and t-BuONa at 100 C in toluene afforded the best results. The reaction occurred with alkyl, aryl, and functionalized substituents in both starting substrates. The indoles were only synthesized with 1-substituted-2-bromoalkenes by cyclization of N-substituted o-bromoanilines (which provided N-substituted indoles). A catalytic combination of Pd2(dba)3 and XPhos was needed for employing this strategy to o-chloroanilines.[31b,44]

 

Ethyl 3-(o-trifluoroacetamidoaryl)-1-propargylic carbonates were reacted with primary or secondary amines to form the N-unsubstituted indole-2-acetamides with the help of 1,10-bis(dimethylphosphino)ferrocene (dppf), Pd2(dba)3, and CO at 80 C in THF (Scheme 25).[95,96] The reaction was employed for the preparation of N-unsubstituted indole 2-acetic acid methyl esters [dppf, Pd2(dba)3, MeOH/THF, CO, 24 h, 80 C].[44] Kondo and coworkers[97] synthesized the indole skeleton through enamine process under solid-phase conditions in which immobilized N-(o-bromo-) and N-(o-iodoaryl) enaminoesters were cyclized to form indolecarboxylate derivatives after a transesterification step (Schemes 26 and 27). The isolated yield increased on adding P(o-tol)3. The Pd2(dba)3.3CHCl3 worked better than Pd(OAc)2 with N-(o-bromoaryl) enaminoesters.


The intramolecular cyclization of immobilized a-acetamido-b-(o-bromophenyl)acrylates was performed as a domino process under solid-phase conditions for the formation of indole through Heck reaction of solid supported N-acetyl-dehydroalanine with 2-bromophenyl triflates or 1,2-dibromobenzenes, then the formed a-acetamido-b-(obromophenyl) acrylate intermediates underwent in situ intramolecular cyclization (Scheme 28).[44,98,99]

 

The 2-substituted bromoalkenes were reacted for the synthesis of 3-substituted indoles. However, it needed N-substituted-o-haloanilines. Thus, the N-alkyl-3-substituted indoles were furnished in higher yields under similar reaction conditions (Scheme 29).[52,100] The stereoselectivity, which afforded congested quaternary carbon centers in the palladium-catalyzed intramolecular Heck cyclizations, can be inverted with a silver salt (Scheme 30).[101] The coordination of angular vinyl group during the insertion step has shown high selectivity in this case.[102]

 

The o-ethynyltrifluoroacetanilide was used for the synthesis of 2-unsubstituted 3-aryl indoles in this process.[103] Much more optimization was required in the reaction of aryl iodides with anilide which possessed an o-terminal alkyne moiety, because under the standard conditions developed for o-alkynyltrifluoroacetanilides, coupling derivatives[104,105] were formed in a significant side reaction. Indeed, under a variety of reaction conditions coupling derivatives were obtained in the presence of a number of phosphine ligands. The coupling derivative was observed in 83% yield from the reaction of o-ethynyltrifluoroacetanilide with p-iodoacetophenone [Pd2(dba)3, 60 C, THF, 7 h] using tris(p-chlorophenyl)phosphine. One more significant side reaction was observed in which 2-unsubstituted 3-aryl indoles were formed with the nucleophilic attack of oxygen at the “internal” carbon of the activated C,C triple bond. The N-/O-cyclization ratio was influenced strongly by both the nature of the catalyst and the solvent. The use of DMSO as the solvent, Pd2(dba)3 as the palladium(0) source, and K2CO3 as the base in the absence of phosphine ligands afforded best results (Scheme 31). Cesium carbonate was also used successfully. The indole was obtained in 80% yield when o-ethynyltrifluoroacetanilide was reacted under same reaction conditions omitting aryl iodides.[44,49b]

 

The 2-substituted 3-acylindoles were synthesized regioselectively from 2-substituted

3-alkynylindole intermediates. The reaction regioselectivity was promoted by the addition of water in high yield in the presence of catalytic amounts of TsOH at room temperature. The regioselectivity of the acid-induced hydration was not influenced in the presence of electron-donating or electron-withdrawing substituents in the alkyne moiety or in the C2-position. The o-alkynyltrifluoroacetanilides and 1-bromoalkynes were reacted through a one-pot cyclization-hydration process for the convenient synthesis of 2-substituted 3-acylindoles and it omitted the isolation of 2-substituted 3-alkynylindoles (Scheme 32).[44,49b,103]

 

2,3-Diarylindoles possess a wide range of biological activities. This reaction is especially suitable for a straightforward synthesis of symmetrical and unsymmetrical 2,3-diarylindoles. The regioselectivity was followed from the sequence of events and is unambiguous during the synthesis of unsymmetrical 2,3-diarylindoles which was the major advantage of this protocol. Good to excellent results were observed using Pd(PPh3)4 catalyst with aryl bromides, iodides, and triflates. Aryl chlorides were more reluctant to undergo oxidative addition to Pd(0) and needed XPhos (Scheme 33),[70] one of the biaryl monophosphines which increased the rate of the oxidative addition of aryl chlorides to Pd(0) species.[106–108] One of the major problems realized in this indole synthesis was solved using this ligand with relatively unreactive precursors of organopalladium complexes, like, the competitive formation of simple 2-substituted indoles, the formation of which does not involve the aryl halide partner.[44,65,67–69]
Metal-catalyzed amide C-arylations (Scheme 34) effectively afford the expected oxindole products.[26,109]

 

This oxindole ring can be formed when aromatic substrates contain a halogen atom situated ortho to a moiety containing a reactive functional group. For example, intramolecular radical cyclizations and Heck cyclizations have been used to form the C3-C4 bond of the oxindole nucleus (Scheme 35).[110–116] Grigg and coworkers[117] described the in situ Pd-catalyzed preparation of tributylstannyl-1,2-carbodialkylidene through one-pot protocol from 1,6-diynes and TBTH which was then further coupled with iodobenzene possessing a proximate alkene group and anion capture to provide the good yields of targeted indoline derivatives (Scheme 36).[91]

 

The alkyl, aryl, and functionalized geminal bromoalkenes participated in an indolization reaction. A new optimization was done with o-chloroanilines. When XPhos was used as a supporting ligand then only the tandem process was achieved. The indoles were synthesized with similar yields to those observed with o-bromoanilines under these conditions[52,118] (Scheme 37).
Spirooxindoles are key intermediates to synthesize (-)-physostigmine, (-)-eptazocine, halenaquinol, and indolizidine alkaloids.[119,120] An indolizidine and spirooxindole skeletons were synthesized as shown in Scheme 38. [121,122]

 

The starting substrates N-(o-halophenyl)allenamides were utilized in a new protocol for the formation of 3-substituted, 2-unsubstituted, and 2,3-disubstituted indoles through an intramolecular carbopalladation/anion capture domino reaction with boron nucleophiles. The 2-silylindoles were synthesized when an appropriate silicon group was selectively introduced to the a-position of the allenamide functionality. The formed 2-silylindoles were substrates for further functionalization at the C-2 position (Scheme 39). Fuwa and Sasaki[123a] described this approach based on the intramolecular carbopalladation/cyclization-anion capture protocol for the synthesis of 2,3-disubstituted indole derivatives. The palladium p-allyl intermediate was formed from allenamides which contain a substituent at the a-position through a facile carbopalladation/cyclization. The formed palladium p-allyl intermediate was then cross-coupled with a number of orgnanoboron species to provide various 2,3-disubstituted indoles.[44,123b]

 

Precedent for competitive oxidative amination in a carboamination reaction was seen previously by the Wolfe group.[124,125] For example, as shown in Scheme 40, in the reaction of N-benzyl-2-allylaniline with 4-bromotoluene to form an indoline, the oxidative amination product N-benzyl-2-methylindole was formed as a byproduct. Furthermore, oxidative amination products can even be preferentially formed over carboamination products with proper ligand choice.

 

The 2-acetylenic anilines en route to 2-amido-indoles were synthesized by aminative cross-coupling of aryl halides through metal-promoted 5-endo-dig cyclization[126–143] (Schemes 41 and 42). The ynamide 7-Br underwent amination in the presence of p-tolNH2 and 2.5 mol% Pd2(dba)3 to afford 2-amido-indole in good yields using either 5 mol% of Buchwald’s X-phos or van Leeuwen’s xantphos as ligands.[144] The reaction time decreased in the presence of X-phos in comparison to xantphos while there was no use of BINAP. On the other hand, the 2-amido-indole was formed in 78% yield by
amination of 7-Cl only with X-phos. In contrast to aryl iodides, aryl chlorides and bromides performed better in this reaction.

 

The nitrogen behaved as an ambivalent atom in this operation. As a nucleophile, it intervened in the N-allylation step and in the cyclization step as a leaving group which favored the synthesis of a p-allylpalladium complex. With a number of o-alkynyltrifluoroacetanilides and allylic carbonates, these methods afforded good results. In one of the method, o-ethynyltrifluoroacetanilide was utilized to provide 2-unsubstituted 3-allylindoles in allowable yields. The substituent present on the central carbon atom of the allylic compound was tolerated, whereas the cyclization reaction was hampered when the sterically encumbered substituents were present at one end of the alkyne moiety or the substitution was available at both termini of the allylic system. The most challenging situation to the regiochemistry of the new C-C bond was faced when there were small steric differences between the two allylic termini. The best results were observed with tris(2,4,6-trimethoxyphenyl)-phosphine (ttmpp) and the reaction afforded remarkable regioselectivity and the less substituted terminus of the allylic system bears the indole unit almost exclusively. Some loss of olefin geometry was observed in this process[44,145] (Scheme 43).

 

Previously in the Wolfe group,[83,146,147] the Pd-catalyzed carboamination of c-(N-arylamino) alkenes and c-(N-Boc-amino) alkenes to afford substituted pyrrolidines has been demonstrated. For example, reaction of a 1-substituted c-(N-arylamino) alkene with 4-bromoanisole gave cis-2,5-disubstituted pyrrolidine and a regioisomer in good yield and diastereoselectivity as a 10:1 mixture of regioisomers (Scheme 44).

 

Conclusion
This review described the utility of palladium catalysts in the construction of nitrogen containing heterocycles. This synthetic approach has a broad utility for the synthesis of a wide range of N-heterocycles and will continue to attract attention in future. In the past decades, several strategies have been identified and pursued in order to establish reliable, efficient, convenient, and environmentally benign synthetic methods. These strategies include the typically mild conditions of Pd-catalysis, compatibility with many diverse types of polar functionality, reactions that exhibit good yield and product
selectivity, and ability to assemble very different molecular frameworks (to explore chemical space).

Over 100,000 products now available from Angene:

CAS No. 10223-33-3

3H-Pyrazol-3-one, 2,4-dihydro-4-(2-hydroxyethyl)-5-methyl-2-phenyl-

Catalog No.:AG0006ZR MDL No.:

MF:C12H14N2O2 MW:218.2518

CAS No. 10223-46-8

5,6-Diazaspiro[2.4]hept-6-en-4-one, 5,7-diphenyl-

Catalog No.:AG0006ZQ MDL No.:

MF:C17H14N2O MW:262.3059

CAS No. 10223-72-0

Benzenamine, N-butyl-2,6-dinitro-4-(trifluoromethyl)-

Catalog No.:AG0006ZP MDL No.:

MF:C11H12F3N3O4 MW:307.2259

CAS No. 10223-90-2

Cyclohexanecarboxamide, 4-[4-[(aminocarbonyl)oxy]phenyl]-2,6-dioxo-

Catalog No.:AG0006ZO MDL No.:

MF:C14H14N2O5 MW:290.2714

CAS No. 10223-91-3

Cyclohexanecarboxamide, 2,6-dioxo-N-phenyl-4-[4-[[(phenylamino)carbonyl]oxy]phenyl]-

Catalog No.:AG0006ZN MDL No.:

MF:C26H22N2O5 MW:442.4633

CAS No. 102236-18-0

Benzenemethanamine, 4-chloro-N-ethyl-, hydrochloride (1:1)

Catalog No.:AG000709 MDL No.:MFCD07106854

MF:C9H13Cl2N MW:206.1122

CAS No. 102236-22-6

Benzene, 1-chloro-2-ethoxy-4-nitro-

Catalog No.:AG000708 MDL No.:MFCD21333109

MF:C8H8ClNO3 MW:201.6070

CAS No. 102236-24-8

Benzene, 4-chloro-1-ethoxy-2-nitro-

Catalog No.:AG000707 MDL No.:

MF:C8H8ClNO3 MW:201.6070

CAS No. 102236-48-6

Cyclohexene, 1-methyl-3,5-bis(methylene)-

Catalog No.:AG000706 MDL No.:

MF:C9H12 MW:120.1916

CAS No. 102236-50-0

Benzenamine, 2-bromo-3,4,6-trimethyl-

Catalog No.:AG000705 MDL No.:

MF:C9H12BrN MW:214.1023

CAS No. 102236-72-6

Propanenitrile, 3-[(4-methoxyphenyl)thio]-

Catalog No.:AG000704 MDL No.:MFCD11134672

MF:C10H11NOS MW:193.2654

CAS No. 102236-74-8

1H-Indole-5,6-diol, 1-ethyl-

Catalog No.:AG000703 MDL No.:

MF:C10H11NO2 MW:177.1998

CAS No. 102236-77-1

3-Quinolinecarboxylic acid, 5,6,7,8-tetrahydro-, hydrochloride (1:1)

Catalog No.:AG000702 MDL No.:

MF:C10H12ClNO2 MW:213.6608

CAS No. 102239-19-0

Pyrrolidine, 3-(diphenylmethoxy)-1-propyl-

Catalog No.:AG000701 MDL No.:

MF:C20H25NO MW:295.4186

CAS No. 10224-03-0

Acetamide, N,N'-(oxydi-4,1-phenylene)bis[2-chloro-

Catalog No.:AG00070G MDL No.:

MF:C16H14Cl2N2O3 MW:353.2000

CAS No. 10224-11-0

2H-Benzocyclohepten-2-one, 3-methoxy-

Catalog No.:AG00070F MDL No.:

MF:C12H10O2 MW:186.2066

CAS No. 10224-14-3

Cyclopropanecarbonitrile, 1,2-diphenyl-

Catalog No.:AG00070E MDL No.:

MF:C16H13N MW:219.2811

CAS No. 10224-18-7

Benzene, 1,1'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis[4-isocyanato-

Catalog No.:AG00070D MDL No.:MFCD00142759

MF:C17H8F6N2O2 MW:386.2480

CAS No. 10224-66-5

Benzenamine, 2,5-dimethoxy-N-methyl-

Catalog No.:AG00070C MDL No.:MFCD11152066

MF:C9H13NO2 MW:167.2050

CAS No. 10224-72-3

1,1-Cyclobutanedicarboxylic acid, 1,1-dimethyl ester

Catalog No.:AG00070B MDL No.:MFCD00082719

MF:C8H12O4 MW:172.1785

CAS No. 10224-98-3

1-Piperidinecarbodithioic acid, phenylmethyl ester

Catalog No.:AG00070A MDL No.:

MF:C13H17NS2 MW:251.4108

CAS No. 102240-88-0

10H-Phenothiazine, 10-[2-(4-ethyl-1-piperazinyl)ethyl]-

Catalog No.:AG000700 MDL No.:

MF:C20H25N3S MW:339.4976

CAS No. 102241-90-7

Benzamide, N,N'-(phenylmethylene)bis[2-nitro-

Catalog No.:AG0006ZZ MDL No.:

MF:C21H16N4O6 MW:420.3749

CAS No. 102242-28-4

1(3H)-Isobenzofuranone, 3-phenyl-3-(phenylmethyl)-

Catalog No.:AG0006ZY MDL No.:

MF:C21H16O2 MW:300.3505

CAS No. 102243-12-9

Benzenamine, 4-[(4,6-dimethyl-2-pyrimidinyl)thio]-

Catalog No.:AG0006ZX MDL No.:MFCD00203030

MF:C12H13N3S MW:231.3167

CAS No. 102244-03-1

Quinazoline, 4-(2-quinolinylthio)-

Catalog No.:AG0006ZW MDL No.:

MF:C17H11N3S MW:289.3543

CAS No. 102244-23-5

6-Hepten-4-yn-3-ol, 1-(decylthio)-2,3,6-trimethyl-

Catalog No.:AG0006ZT MDL No.:

MF:C20H36OS MW:324.5642

CAS No. 102244-43-9

Piperidine, 1-[[3-(3-bromopropoxy)phenyl]methyl]-

Catalog No.:AG0006ZS MDL No.:

MF:C15H22BrNO MW:312.2453

CAS No. 102244-91-7

2-Propenoic acid, 2-azido-3-(4-hydroxyphenyl)-, methyl ester, (2Z)-

Catalog No.:AG00070Y MDL No.:

MF:C10H9N3O3 MW:219.1968

CAS No. 102245-02-3

2-Propenoic acid, 2-(acetylamino)-3-(4-chlorophenyl)-, methyl ester, (2Z)-

Catalog No.:AG00070X MDL No.:

MF:C12H12ClNO3 MW:253.6816

CAS No. 102245-18-1

Pyrrolidine, 1-(1-cyclohexen-1-yl)-2-[[(trimethylsilyl)oxy]methyl]-, (2S)-

Catalog No.:AG00070W MDL No.:

MF:C14H27NOSi MW:253.4558

CAS No. 102245-65-8

2-Butynoic acid, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-

Catalog No.:AG00070V MDL No.:MFCD06658386

MF:C10H18O3Si MW:214.3336

CAS No. 102246-82-2

Ethanamine, 2-(4-methoxyphenoxy)-N-methyl-

Catalog No.:AG00070U MDL No.:MFCD06384304

MF:C10H15NO2 MW:181.2316

CAS No. 1022462-94-7

Tricyclo[7.1.0.04,6]decane-5-carboxylic acid, 10,10-dichloro-

Catalog No.:AG00070H MDL No.:MFCD00448783

MF:C11H14Cl2O2 MW:249.1337

CAS No. 102247-22-3

Phenol, 2-[[[4-phenyl-5-(2-phenyldiazenyl)-2-thiazolyl]imino]methyl]-

Catalog No.:AG00070T MDL No.:

MF:C22H16N4OS MW:384.4536

CAS No. 102247-34-7

Pyridinium, 4-[2-[4-(dimethylamino)phenyl]ethenyl]-1-hexadecyl-

Catalog No.:AG00070S MDL No.:

MF:C31H49N2+ MW:449.7342

CAS No. 102247-85-8

1-Hexadecanesulfonamide, N-(2,3-dihydro-3-oxo-1H-inden-5-yl)-

Catalog No.:AG00070R MDL No.:

MF:C25H41NO3S MW:435.6629

CAS No. 102248-87-3

Propanedioic acid, 2-[(diethoxyphosphinyl)methyl]-, 1-ethyl ester

Catalog No.:AG00070Q MDL No.:

MF:C10H18O7P- MW:281.2195

CAS No. 102248-96-4

L-Alanine, N-(2,5-dimethyloxazolo[5,4-d]pyrimidin-7-yl)-

Catalog No.:AG00070P MDL No.:

MF:C10H12N4O3 MW:236.2273

CAS No. 102248-98-6

Glycine, N-(2,5-dimethyloxazolo[5,4-d]pyrimidin-7-yl)-N-methyl-

Catalog No.:AG00070O MDL No.:

MF:C10H12N4O3 MW:236.2273

CAS No. 102249-45-6

3-Pyridinamine, 2,4-dibromo-

Catalog No.:AG00070N MDL No.:MFCD00234046

MF:C5H4Br2N2 MW:251.9067

CAS No. 102249-52-5

2(1H)-Pyridinone, 4-hydroxy-5-phenyl-

Catalog No.:AG00070M MDL No.:

MF:C11H9NO2 MW:187.1947

CAS No. 102249-56-9

3-Pyridinamine, 2-bromo-5-phenyl-

Catalog No.:AG00070L MDL No.:MFCD27939357

MF:C11H9BrN2 MW:249.1066

CAS No. 102249-66-1

1H-2-Benzopyran, 3,4-dihydro-1,3-dimethyl-, (1R,3S)-rel-

Catalog No.:AG00070K MDL No.:

MF:C11H14O MW:162.2283

CAS No. 102249-67-2

1H-2-Benzopyran, 3,4-dihydro-1,3-dimethyl-, (1R,3R)-rel-

Catalog No.:AG00070J MDL No.:

MF:C11H14O MW:162.2283

CAS No. 102249-87-6

2(1H)-Isoquinolinecarboxamide, 1-cyano-N,N-dimethyl-

Catalog No.:AG00070I MDL No.:

MF:C13H13N3O MW:227.2618

CAS No. 10225-01-1

Carbamodithioic acid, dimethyl-, 1,4-butanediyl ester (9CI)

Catalog No.:AG000715 MDL No.:

MF:C10H20N2S4 MW:296.5392

CAS No. 10225-09-9

4-Morpholinecarbodithioic acid, 2-benzothiazolyl ester

Catalog No.:AG000714 MDL No.:

MF:C12H12N2OS3 MW:296.4315

CAS No. 10225-31-7

2,4-Pentanedione, 3-(3-methylbutyl)-

Catalog No.:AG000713 MDL No.:

MF:C10H18O2 MW:170.2487

CAS No. 10225-38-4

1,3-Butanedione, 1-phenyl-2-(2-propen-1-yl)-

Catalog No.:AG000712 MDL No.:

MF:C13H14O2 MW:202.2491

CAS No. 10225-74-8

2H-Pyran-3-ol, tetrahydro-2-methoxy-, 3-benzoate, (2S,3R)-

Catalog No.:AG000711 MDL No.:

MF:C13H16O4 MW:236.2637

CAS No. 10225-80-6

2-Thiazolidinethione, 3-ethyl-5-hydroxy-5-(1,2,3,4-tetrahydroxybutyl)-

Catalog No.:AG000710 MDL No.:

MF:C9H17NO5S2 MW:283.3650

CAS No. 10225-81-7

2-Thiazolidinethione, 5-hydroxy-3-methyl-5-(1,2,3,4-tetrahydroxybutyl)-

Catalog No.:AG00070Z MDL No.:

MF:C8H15NO5S2 MW:269.3384

CAS No. 10225-82-8

2-Thiazolidinethione, 3-butyl-5-hydroxy-5-(1,2,3,4-tetrahydroxybutyl)-

Catalog No.:AG00071U MDL No.:

MF:C11H21NO5S2 MW:311.4181

CAS No. 10225-93-1

Diazene, 1,2-bis[4-(hexyloxy)phenyl]-

Catalog No.:AG00071T MDL No.:

MF:C24H34N2O2 MW:382.5390

CAS No. 10225-94-2

Diazene, bis[4-(heptyloxy)phenyl]- (9CI)

Catalog No.:AG00071S MDL No.:

MF:C26H38N2O2 MW:410.5921

CAS No. 10225-98-6

1,5-Heptanedione, 4,4,6-trimethyl-1,3-diphenyl-

Catalog No.:AG00071R MDL No.:

MF:C22H26O2 MW:322.4406

CAS No. 102250-17-9

Tetratriacontahexaenoic acid, (?Z,?Z,?Z,?Z,?Z,?Z)-

Catalog No.:AG00071Q MDL No.:

MF:C34H56O2 MW:496.8072

CAS No. 102250-75-9

2-Butenoic acid, 4-(diethylamino)-4-oxo-, methyl ester, (2E)-

Catalog No.:AG00071P MDL No.:

MF:C9H15NO3 MW:185.2203

CAS No. 102250-77-1

2-Butenoic acid, 4-(diethylamino)-4-oxo-, 1-methylethyl ester, (E)- (9CI)

Catalog No.:AG00071O MDL No.:

MF:C11H19NO3 MW:213.2735

CAS No. 1022507-42-1

2-Pyridinepropanethiol

Catalog No.:AG000716 MDL No.:

MF:C8H11NS MW:153.2446

CAS No. 102251-78-5

Pyrene, 4,5,9,10-tetrahydro-1-methyl-

Catalog No.:AG00071N MDL No.:

MF:C17H16 MW:220.3089

CAS No. 102252-25-5

1,2,4-Oxadiazole-5-acetonitrile, 3-benzoyl-

Catalog No.:AG00071M MDL No.:

MF:C11H7N3O2 MW:213.1922

CAS No. 102253-13-4

Octadecanamide, N-(3-hydroxyphenyl)-

Catalog No.:AG00071L MDL No.:

MF:C24H41NO2 MW:375.5878

CAS No. 102253-20-3

Urea, N-(4-hydroxyphenyl)-N'-octadecyl-

Catalog No.:AG00071K MDL No.:

MF:C25H44N2O2 MW:404.6291

CAS No. 102253-41-8

Octadecanoic acid, 2,2-dimethylpropyl ester

Catalog No.:AG00071J MDL No.:

MF:C23H46O2 MW:354.6101

CAS No. 102253-46-3

Piperazinone, 1,1'-(1,2-ethanediyl)bis[4-hydroxy-3,3,5,5-tetramethyl- (9CI)

Catalog No.:AG00071I MDL No.:

MF:C18H34N4O4 MW:370.4870

CAS No. 102253-71-4

Pyridine, 4-(1,2,3-thiadiazol-4-yl)-

Catalog No.:AG00071H MDL No.:

MF:C7H5N3S MW:163.1997

CAS No. 102254-08-0

2-Propenamide, 2-methyl-N-[(phenylamino)carbonyl]-

Catalog No.:AG00071G MDL No.:

MF:C11H12N2O2 MW:204.2252

CAS No. 102254-11-5

Carbamic acid, N-(2-methyl-1-oxo-2-propen-1-yl)-, methyl ester

Catalog No.:AG00071F MDL No.:

MF:C6H9NO3 MW:143.1406

CAS No. 102254-70-6

Benzenecarbothioamide, N-[(dimethylamino)methylene]-, [N(E)]-

Catalog No.:AG00071E MDL No.:MFCD00116675

MF:C10H12N2S MW:192.2807

CAS No. 102255-53-8

Benzoic acid, 4-(decyloxy)-, 4-(decyloxy)phenyl ester

Catalog No.:AG00071D MDL No.:

MF:C33H50O4 MW:510.7477

CAS No. 102259-64-3

1,4-Pentanediamine, N4-(7-chloro-6-nitro-4-quinolinyl)-N1,N1-diethyl-, phosphate (1:2)

Catalog No.:AG00071C MDL No.:

MF:C18H31ClN4O10P2 MW:560.8601

CAS No. 102259-65-4

1,3-Propanediamine, N'-(7-chloro-6-nitro-4-quinolinyl)-N,N-diethyl-, phosphate (1:2) (9CI)

Catalog No.:AG00071B MDL No.:

MF:C16H25ClN4O7P2 MW:482.7928

CAS No. 102259-66-5

1,2-Ethanediamine, N,N-diethyl-N'-(6-nitro-4-quinolinyl)-, phosphate (1:2) (9CI)

Catalog No.:AG00071A MDL No.:

MF:C15H24N4O7P2 MW:434.3212

CAS No. 102259-68-7

1,4-Pentanediamine, N1,N1-diethyl-N4-(6-nitro-4-quinolinyl)-, phosphate (1:2)

Catalog No.:AG000719 MDL No.:

MF:C18H32N4O10P2 MW:526.4150

CAS No. 102259-69-8

1,3-Propanediamine, N,N-diethyl-N'-(6-nitro-4-quinolinyl)-, phosphate (1:2) (9CI)

Catalog No.:AG000718 MDL No.:

MF: MW:

CAS No. 102259-70-1

2-Quinolineethanol, 6-(dimethylamino)-α,α-bis(trifluoromethyl)-

Catalog No.:AG000717 MDL No.:

MF:C15H14F6N2O MW:352.2749

CAS No. 102259-71-2

1(2H)-Quinolineethanamine, 3,4-dihydro-2-methyl-, acetate (1:1)

Catalog No.:AG00072C MDL No.:

MF:C14H22N2O2 MW:250.3367

CAS No. 102259-74-5

Quinoline, 1,2,3,4-tetrahydro-6-methoxy-1-[2-(1-piperidinyl)ethyl]-, hydrochloride (1:2)

Catalog No.:AG00072B MDL No.:

MF:C17H28Cl2N2O MW:347.3230

CAS No. 1022594-77-9

Carbamic acid, N-[[4-[[(3-aminophenyl)amino]carbonyl]phenyl]methyl]-, phenylmethyl ester

Catalog No.:AG00071W MDL No.:

MF:C22H21N3O3 MW:375.4204

CAS No. 10226-28-5

2H-Pyran-5-carboxylic acid, 3,4-dihydro-6-methyl-, ethyl ester

Catalog No.:AG00072J MDL No.:MFCD00143102

MF:C9H14O3 MW:170.2057

CAS No. 10226-29-6

2-Hexanone, 6-bromo-

Catalog No.:AG00072I MDL No.:MFCD00044891

MF:C6H11BrO MW:179.0549

CAS No. 10226-30-9

2-Hexanone, 6-chloro-

Catalog No.:AG00072H MDL No.:MFCD00191625

MF:C6H11ClO MW:134.6039

CAS No. 10226-37-6

1H-Indazole-3-acetic acid, 5-methoxy-

Catalog No.:AG00072G MDL No.:MFCD02929861

MF:C10H10N2O3 MW:206.1980

CAS No. 10226-54-7

1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-7-(5-oxohexyl)-

Catalog No.:AG00072F MDL No.:MFCD00867151

MF:C13H18N4O3 MW:278.3070

CAS No. 10226-59-2

1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl-1-(6-oxoheptyl)-

Catalog No.:AG00072E MDL No.:

MF:C14H20N4O3 MW:292.3336

CAS No. 10226-60-5

1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl-1-(4-oxopentyl)-

Catalog No.:AG00072D MDL No.:

MF:C12H16N4O3 MW:264.2804

CAS No. 102260-53-7

2,5-Cyclohexadien-1-one, 4-bromo-4-ethyl-

Catalog No.:AG00072A MDL No.:

MF:C8H9BrO MW:201.0605

CAS No. 1022605-11-3

Carbamic acid, N-[4-(4-methylphenyl)-3-pyrrolidinyl]-, 1,1-dimethylethyl ester

Catalog No.:AG00071V MDL No.:MFCD05662446

MF:C16H24N2O2 MW:276.3740

CAS No. 102261-93-8

1,2-Dioxolane, 5-ethenyl-3,3-diphenyl-

Catalog No.:AG000729 MDL No.:

MF:C17H16O2 MW:252.3077

CAS No. 102262-34-0

Sulfuric acid, ammonium silver(1+) salt (9CI)

Catalog No.:AG000728 MDL No.:

MF:AgH4NO4S MW:221.9693

CAS No. 102262-55-5

2-Phenazinamine, N,5-bis(4-chlorophenyl)-3,5-dihydro-3-imino-

Catalog No.:AG000727 MDL No.:

MF:C24H16Cl2N4 MW:431.3166

CAS No. 102266-15-9

2-Pyridinamine, 3-nitro-6-phenyl-

Catalog No.:AG000726 MDL No.:MFCD16556297

MF:C11H9N3O2 MW:215.2081

CAS No. 102266-56-8

3-Butenoic acid, 3-amino-4,4-dicyano-, methyl ester

Catalog No.:AG000725 MDL No.:

MF:C7H7N3O2 MW:165.1494

CAS No. 102266-59-1

3-Pyridinecarbonitrile, 4-amino-2-ethoxy-1,6-dihydro-6-oxo-

Catalog No.:AG000724 MDL No.:

MF:C8H9N3O2 MW:179.1760

CAS No. 102266-85-3

Carbonothioic dihydrazide, bis(1-methylpropylidene)- (9CI)

Catalog No.:AG000723 MDL No.:

MF:C9H18N4S MW:214.3310

CAS No. 102267-84-5

5H-Pyrrolo[3,4-b]pyridine-5,7(6H)-dione, 3-ethyl-6-phenyl-

Catalog No.:AG000722 MDL No.:

MF:C15H12N2O2 MW:252.2680

CAS No. 102267-86-7

5H-Pyrrolo[3,4-b]pyridine-5,7(6H)-dione, 6-phenyl-3-propyl-

Catalog No.:AG000721 MDL No.:

MF:C16H14N2O2 MW:266.2946

CAS No. 102267-93-6

5H-Pyrrolo[3,4-b]pyridine-5,7(6H)-dione, 3-methyl-6-phenyl-

Catalog No.:AG000720 MDL No.:

MF:C14H10N2O2 MW:238.2414

CAS No. 102268-13-3

Furo[3,4-b]pyridine-5,7-dione, 3-propyl-

Catalog No.:AG00071Z MDL No.:

MF:C10H9NO3 MW:191.1834

CAS No. 102268-15-5

2,3-Pyridinedicarboxylic acid, 5-ethyl-

Catalog No.:AG00071Y MDL No.:MFCD00071733

MF:C9H9NO4 MW:195.1721

CAS No. 102268-23-5

Furo[3,4-b]pyridine-5,7-dione, 3-ethyl-

Catalog No.:AG00071X MDL No.:MFCD15144179

MF:C9H7NO3 MW:177.1568

CAS No. 102269-42-1

Benzenamine, 3-(2-furanyl)-

Catalog No.:AG000735 MDL No.:MFCD04039071

MF:C10H9NO MW:159.1846

CAS No. 102269-52-3

1-Azoniabicyclo[2.2.2]octane, 3-(4-chlorophenyl)-3-hydroxy-1-methyl-

Catalog No.:AG000734 MDL No.:

MF:C14H19ClNO+ MW:252.7598

CAS No. 102269-67-0

8-Quinolinol, 5-[(dioctylamino)methyl]-

Catalog No.:AG000733 MDL No.:

MF:C26H42N2O MW:398.6245

CAS No. 102269-68-1

8-Quinolinol, 5-[(octyloxy)methyl]-

Catalog No.:AG000732 MDL No.:

MF:C18H25NO2 MW:287.3966

CAS No. 10227-17-5

α-D-Glucofuranose, 1,2-O-(1-methylethylidene)-5-thio-, 3,5,6-triacetate

Catalog No.:AG000738 MDL No.:

MF: MW:

CAS No. 10227-18-6

α-D-Glucopyranose, 5-thio-, 1,2,3,4,6-pentaacetate

Catalog No.:AG000737 MDL No.:

MF:C16H22O10S MW:406.4049

CAS No. 10227-63-1

Ethanone, 1-(1H-benzimidazol-2-yl)-2-bromo-

Catalog No.:AG000736 MDL No.:MFCD28672492

MF:C9H7BrN2O MW:239.0687

CAS No. 102271-77-2

2(3H)-Furanone, 3-([1,1'-biphenyl]-4-ylmethylene)dihydro-, (3E)-

Catalog No.:AG000731 MDL No.:

MF:C17H14O2 MW:250.2919

CAS No. 102271-78-3

2(3H)-Furanone, 3-[[4-(dimethylamino)phenyl]methylene]dihydro-, (3E)-

Catalog No.:AG000730 MDL No.:

MF:C13H15NO2 MW:217.2637

CAS No. 102271-83-0

2(3H)-Furanone, 3-(1,3-benzodioxol-5-ylmethylene)dihydro-, (E)- (9CI)

Catalog No.:AG00072Z MDL No.:

MF:C12H10O4 MW:218.2054

CAS No. 102272-30-0

Octanoic acid, 2,2-dichloro-

Catalog No.:AG00072Y MDL No.:

MF:C8H14Cl2O2 MW:213.1016

CAS No. 102272-92-4

Carbamimidothioic acid, (phenylamino)methyl ester

Catalog No.:AG00072X MDL No.:

MF:C8H11N3S MW:181.2580

CAS No. 102273-13-2

1,1-Ethenediamine, N-[2-[[[2-[(dimethylamino)methyl]-4-thiazolyl]methyl]sulfinyl]ethyl]-N'-methyl-2-nitro-

Catalog No.:AG00072W MDL No.:

MF:C12H21N5O3S2 MW:347.4568

CAS No. 102273-61-0

3-Hexanone, 5-hydroxy-, (5S)-

Catalog No.:AG00072V MDL No.:

MF:C6H12O2 MW:116.1583

CAS No. 102273-62-1

8-Nonen-4-one, 2-hydroxy-, (2S)-

Catalog No.:AG00072U MDL No.:

MF:C9H16O2 MW:156.2221

CAS No. 102273-63-2

3-Heptanone, 5-hydroxy-, (5R)-

Catalog No.:AG00072T MDL No.:

MF:C7H14O2 MW:130.1849

CAS No. 102273-81-4

Phenol, 4-[[(4-methylphenyl)methyl]thio]-

Catalog No.:AG00072S MDL No.:

MF:C14H14OS MW:230.3254

CAS No. 102273-84-7

2-Naphthalenol, 5,8-dimethyl-

Catalog No.:AG00072R MDL No.:MFCD24718576

MF:C12H12O MW:172.2231

CAS No. 102274-25-9

Propanoic acid, 3-amino-2-[(aminoiminomethyl)thio]-, hydrobromide (1:2)

Catalog No.:AG00072Q MDL No.:

MF:C4H11Br2N3O2S MW:325.0220

CAS No. 102274-58-8

Hexanamide, N-[4-(2-formylhydrazinyl)phenyl]-

Catalog No.:AG00072P MDL No.:

MF:C13H19N3O2 MW:249.3089

CAS No. 102275-51-4

Ethanol, 2-[2-(1,3-dioxan-2-yl)ethoxy]-

Catalog No.:AG00072O MDL No.:

MF:C8H16O4 MW:176.2102

CAS No. 102275-60-5

9H-Xanthen-9-one, 3-[[3-(4,5-dihydro-5,5-dimethyl-4-oxo-2-furanyl)-2-butenyl]oxy]-, (E)- (9CI)

Catalog No.:AG00072N MDL No.:

MF:C23H20O5 MW:376.4019

CAS No. 102275-68-3

Propanoic acid, 2-methyl-, 6-methyl-2-naphthalenyl ester

Catalog No.:AG00072M MDL No.:

MF:C15H16O2 MW:228.2863

CAS No. 102275-87-6

2-Thiazolidinecarboxylic acid, 4-hydroxy-

Catalog No.:AG00072L MDL No.:

MF:C4H7NO3S MW:149.1683

© 2019 Angene International Limited. All rights Reserved.